from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0815c/cysA2

LFCtreatmentdescriptionclass of inhibitor

-0.251

Amikacinug/mL Amikacintranslation

-0.187

Cap5-10ug/mL Capreomycintranslation

0.840

Rox10-50 ug/mL Roxithromycintranslation

1.391

SM2-5 ug/mL Streptomycintranslation

0.157

Tet5-10 ug/mL Tetracyclinetranslation

-0.839

Rif0.2-5ug/mL Rifampicintranscription

-0.275

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.307

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.090

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.104

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.376

Clofazimine10-13 ug/mL Clofaziminerespiration

0.210

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.369

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.074

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.719

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.315

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.684

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.752

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.155

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.101

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.525

KCN5-20 ug/mL Potassium cyaniderespiration

0.415

NaN30.2-2 mM Sodium aziderespiration

1.851

Nigericin50 uM Nigericinrespiration

-1.092

TRC10-150 ug/mL Triclosanrespiration

0.210

TRZ10-25 ug/mL Thioridazinerespiration

0.846

Valinomycin0.5-10 uM Valinomycinrespiration

0.335

ZnSO42 mM ZnSO4respiration

2.734

menadione6-10 ug/mL Menadionerespiration

-0.330

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.352

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.589

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.037

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.996

NRP_1Non-replicating persistence stage 1dosRassociated

0.390

Amp0.2mg/mL AmpicillincellWall

0.239

Cephalexin20-100 ug/mL CephalexincellWall

0.825

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.240

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.097

EMB10-20 ug/mL EthambutolcellWall

0.662

Eta12-40 ug/mL EthionamidecellWall

0.760

INH0.2-0.4 ug/mL IsoniazidcellWall

0.317

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.625

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.733

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.009

BZA0.12 mg/mL BenzamidearomaticAmides

-1.366

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.121

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.447

H2O24 mM hydrogen peroxideDNAdamaging

-0.064

Levo10 ug/mL LevofloxacinDNAdamaging

0.344

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.044

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.022

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.466

UVUV-irradiationDNAdamaging

1.568

ARP41-4 ug/mL Antitubercular compound ARP4?

0.459

Antimycin12.5-50 ug/mL Antimycin A?

0.597

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.122

PA_110-50 ug/mL Antitubercular compound PA-1?

0.247

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.886

PA8240.2-2 ug/mL PA-824?

0.813

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.037

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.124

Verapamil50 uM Verapamil?

0.660

mercaptoethanol2 mM 2-Mercaptoethanol?

0.481

methoxatin10-20 ug/mL Methoxatin?